Phenotypic screening in drug discovery continues to be revived With all the expectation of offering promising lead compounds and drug targets and increasing the results charge of drug acceptance. Having said that, target identification remains a major bottleneck in phenotype-based drug discovery. We determined the lead compounds K542 and K405 https://cfm-292468.dbblog.net/58553255/the-best-side-of-dimethandrolone-undecanoate